T1	Outcomes 880 893	spectrometry.
T2	Outcomes 894 909	RESULTS Insulin
T3	Outcomes 964 990	and EX (19.2 ± 12.9%)
T4	Outcomes 1068 1103	decreases in DIWL compared with EX.
T5	Outcomes 1104 1133	Muscle glycogen, IMTG content
T6	Outcomes 1229 1233	with
T7	Outcomes 1276 1296	(-12.4 ± 14.6%)
T8	Outcomes 1345 1373	with EX (-33.7 ± 11.2%)
T9	Outcomes 1394 1413	Dihydroceramide was
T10	Outcomes 1434 1448	interventions.
T11	Outcomes 1449 1488	Sphingosine was decreased only with EX.
T12	Outcomes 1489 1505	Changes in total
T13	Outcomes 1555 1602	not correlate with changes in glucose disposal.
T14	Outcomes 1603 1620	Stearoyl-coenzyme
T15	Outcomes 1695 1749	p < 0.05), but increased with EX (19.6 ± 7.4%
